From a Wiley News Release:
Wiley today announced the launch of Wiley AI Gateway, the industry’s first AI-native research intelligence platform that provides researchers access to trusted content from world-leading scholarly publishers through a single endpoint.
Unlike closed ecosystems that require researchers to adopt proprietary tools, Wiley AI Gateway prioritizes intentional interoperability, seamlessly integrating scholarly content and data subscriptions with today’s leading AI platforms. Anthropic’s Claude, AWS marketplace, Mistral AI’s Le Chat and Perplexity all connect to the AI Gateway.
[Clip]
The AI Gateway employs advanced content transformation technology to convert scholarly and expert content into AI-optimized formats while preserving citation integrity, methodological context, and peer-review validation. This sophisticated enrichment process, combined with an endpoint built on the Model Context Protocol (MCP), ensures that AI tools can effectively understand, synthesize, and cite research content with the accuracy and reliability that scientific discovery requires.
[Clip]
Wiley AI Gateway enables any publisher to connect to leading AI platforms while protecting and controlling the use of their content and maintaining their independence. Publishers including Sage and American Society for Microbiology (ASM) – two of Wiley’s Atypon customers – will be joining the network with additional world-class publishers also participating to create an industry-wide solution for trustworthy AI-powered research.
[Clip]
Building upon Wiley’s AI collaborations throughout 2025, the AI Gateway is already supporting key initiatives: The European Space Agency’s Φ-lab is using it to bring scholarly content into the Earth Virtual Expert (EVE), and Wiley collaborated with Amazon Web Services (AWS) to launch a generative AI agent for scientific literature search on AWS, the first of its kind from a publisher on AWS.
Learn More, Read the Complete Announcement (about 620 words)
Read original article: Read More
Discover more from DrWeb's Domain
Subscribe to get the latest posts sent to your email.
